Said Saim
Chief Tech/Sci/R&D Officer bei EYEPOINT PHARMACEUTICALS, INC.
Profil
Said Saim is currently working as the Chief Technology Officer & Senior VP at EyePoint Pharmaceuticals, Inc. Prior to his current position, he worked as the Senior Director-Pharmaceutical Development at Collegium Pharmaceutical, Inc. from 2008 to 2013.
He also held the position of Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and Assistant Research Professor at Higuchi Bioscience Center.
Dr. Saim completed his graduate and doctorate degrees at the University of Kansas.
Aktive Positionen von Said Saim
Unternehmen | Position | Beginn |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10.06.2019 |
Ehemalige bekannte Positionen von Said Saim
Unternehmen | Position | Ende |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Ausbildung von Said Saim
University of Kansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Higuchi Bioscience Center |